Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Digital Diabetes Management Market
5.1. COVID-19 Landscape: Digital Diabetes Management Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Digital Diabetes Management Market, By Product
8.1. Digital Diabetes Management Market, by Product, 2023-2032
8.1.1. Devices
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Application
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Data Management Software & Platforms
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Services
8.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Digital Diabetes Management Market, By Device Type
9.1. Digital Diabetes Management Market, by Device Type, 2023-2032
9.1.1. Handheld Devices
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Wearable Devices
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Digital Diabetes Management Market, By Patient Type
10.1. Digital Diabetes Management Market, by Patient Type, 2023-2032
10.1.1. Type 1
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Type 2
10.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Digital Diabetes Management Market, By App
11.1. Digital Diabetes Management Market, by App, 2023-2032
11.1.1. Digital Diabetes Management Apps
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Weight & Diet Management Apps
11.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Digital Diabetes Management Market, By End-Use
12.1. Digital Diabetes Management Market, by End-Use, 2023-2032
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast (2020-2032)
12.1.2. Home Settings
12.1.2.1. Market Revenue and Forecast (2020-2032)
12.1.3. Diagnostic Centers& Clinics
12.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 13. Global Digital Diabetes Management Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2020-2032)
13.1.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.1.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.1.4. Market Revenue and Forecast, by App (2020-2032)
13.1.5. Market Revenue and Forecast, by End-Use (2020-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.1.6.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.1.6.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.1.6.4. Market Revenue and Forecast, by App (2020-2032)
13.1.7. Market Revenue and Forecast, by End-Use (2020-2032)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Product (2020-2032)
13.1.8.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.1.8.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.1.8.4. Market Revenue and Forecast, by App (2020-2032)
13.1.8.5. Market Revenue and Forecast, by End-Use (2020-2032)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.2.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.2.4. Market Revenue and Forecast, by App (2020-2032)
13.2.5. Market Revenue and Forecast, by End-Use (2020-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.6.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.2.6.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.2.7. Market Revenue and Forecast, by App (2020-2032)
13.2.8. Market Revenue and Forecast, by End-Use (2020-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.9.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.2.9.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.2.10. Market Revenue and Forecast, by App (2020-2032)
13.2.11. Market Revenue and Forecast, by End-Use (2020-2032)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.12.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.2.12.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.2.12.4. Market Revenue and Forecast, by App (2020-2032)
13.2.13. Market Revenue and Forecast, by End-Use (2020-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.14.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.2.14.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.2.14.4. Market Revenue and Forecast, by App (2020-2032)
13.2.15. Market Revenue and Forecast, by End-Use (2020-2032)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.3.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.3.4. Market Revenue and Forecast, by App (2020-2032)
13.3.5. Market Revenue and Forecast, by End-Use (2020-2032)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.6.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.3.6.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.3.6.4. Market Revenue and Forecast, by App (2020-2032)
13.3.7. Market Revenue and Forecast, by End-Use (2020-2032)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.8.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.3.8.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.3.8.4. Market Revenue and Forecast, by App (2020-2032)
13.3.9. Market Revenue and Forecast, by End-Use (2020-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.10.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.3.10.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.3.10.4. Market Revenue and Forecast, by App (2020-2032)
13.3.10.5. Market Revenue and Forecast, by End-Use (2020-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.11.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.3.11.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.3.11.4. Market Revenue and Forecast, by App (2020-2032)
13.3.11.5. Market Revenue and Forecast, by End-Use (2020-2032)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.4.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.4.4. Market Revenue and Forecast, by App (2020-2032)
13.4.5. Market Revenue and Forecast, by End-Use (2020-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.6.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.4.6.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.4.6.4. Market Revenue and Forecast, by App (2020-2032)
13.4.7. Market Revenue and Forecast, by End-Use (2020-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.8.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.4.8.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.4.8.4. Market Revenue and Forecast, by App (2020-2032)
13.4.9. Market Revenue and Forecast, by End-Use (2020-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.10.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.4.10.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.4.10.4. Market Revenue and Forecast, by App (2020-2032)
13.4.10.5. Market Revenue and Forecast, by End-Use (2020-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.11.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.4.11.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.4.11.4. Market Revenue and Forecast, by App (2020-2032)
13.4.11.5. Market Revenue and Forecast, by End-Use (2020-2032)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2020-2032)
13.5.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.5.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.5.4. Market Revenue and Forecast, by App (2020-2032)
13.5.5. Market Revenue and Forecast, by End-Use (2020-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.5.6.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.5.6.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.5.6.4. Market Revenue and Forecast, by App (2020-2032)
13.5.7. Market Revenue and Forecast, by End-Use (2020-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2020-2032)
13.5.8.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.5.8.3. Market Revenue and Forecast, by Patient Type (2020-2032)
13.5.8.4. Market Revenue and Forecast, by App (2020-2032)
13.5.8.5. Market Revenue and Forecast, by End-Use (2020-2032)
Chapter 14. Company Profiles
14.1. Bayer AG
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Medtronic
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Roche Diagnostics
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Dexcom Inc. LifeScan Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. AgaMatrix
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. One Drop
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Abbott Laboratories
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Ascensia Diabetes Care
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. ARKRAY Inc
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. ACON Laboratories
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client